Bourne Partners (“Bourne”), a leading financial services firm specializing in the pharma, pharma services, OTC and consumer health sectors announced the appointment of Dr. Martin Zentgraf, as a Senior Advisor to the firm.

Based in Hamburg, Germany, Martin has 35 years of leadership in the European pharma and medtech industry, including 6 years as chairman of the Federal Association of the Pharmaceutical Industry and more than 10 years as a Board Member. Most recently, Martin was the Managing Director and Speaker of the Board of management of Desitin Arzneimittel GmbH, a European specialty pharmaceutical company focused on the CNS and rare diseases markets. While at Desitin he was responsible generally for the whole company with a focus on strategic direction, M&A and other business development initiatives and for the commercial organization.